Literature DB >> 21814193

The use of beat-to-beat electrocardiogram analysis to distinguish QT/QTc interval changes caused by moxifloxacin from those caused by vardenafil.

A A Fossa1, G Langdon, J-P Couderc, M Zhou, B Darpo, F Wilson, R Wallis, J D Davis.   

Abstract

QT correction factors (QTc) can cause errors in the interpretation of drug effects on cardiac repolarization because they do not adequately differentiate changes when heart rate or autonomic state deviates from the baseline QT/RR interval relationship. The purpose of our study was to determine whether the new method of QT interval dynamic beat-to-beat (QTbtb) analysis could better discriminate between impaired repolarization caused by moxifloxacin and normal autonomic changes induced by subtle reflex tachycardia after vardenafil. Moxifloxacin produced maximum mean increases of 13-14 ms in QTbtb, QTcF, and QTcI after 4 h. After vardenafil administration, a 10-ms effect could be excluded at all time points with QTbtb but not with QTcF or QTcI. Subset analysis of the vardenafil upper pharmacokinetic quartile showed that the upper bound of QTcF and QTcI was >10 ms, whereas that of QTbtb was <8 ms. This study demonstrated that newer methods of electrocardiogram (ECG) analysis can differentiate changes in the QT interval to improve identification of proarrhythmia risk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21814193     DOI: 10.1038/clpt.2011.139

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

Review 1.  Beat-to-beat ECG restitution: A review and proposal for a new biomarker to assess cardiac stress and ventricular tachyarrhythmia vulnerability.

Authors:  Anthony A Fossa
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05-12       Impact factor: 1.468

Review 2.  Vardenafil orodispersible tablet.

Authors:  Mark Sanford
Journal:  Drugs       Date:  2012-01-01       Impact factor: 9.546

Review 3.  The Challenges of Predicting Drug-Induced QTc Prolongation in Humans.

Authors:  Jean-Pierre Valentin; Peter Hoffmann; Catherine Ortemann-Renon; John Koerner; Jennifer Pierson; Gary Gintant; James Willard; Christine Garnett; Matthew Skinner; Hugo M Vargas; Todd Wisialowski; Michael K Pugsley
Journal:  Toxicol Sci       Date:  2022-04-26       Impact factor: 4.109

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.